• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt.一名患有门腔分流血栓形成的肝硬化患者出现失代偿性门脉肺动脉高压。
World J Gastroenterol. 2007 Dec 21;13(47):6439-40. doi: 10.3748/wjg.v13.i47.6439.
2
Successful management of portopulmonary hypertension with beraprost.波生坦成功治疗门脉性肺动脉高压。
Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1503-5. doi: 10.1097/MEG.0b013e32833f2259.
3
The Role of TIPS in patients with Refractory Ascites and Portal Vein Thrombosis.经颈静脉肝内门体分流术在难治性腹水和门静脉血栓形成患者中的作用
Ann Hepatol. 2017 Jul-Aug;16(4):619-620. doi: 10.5604/01.3001.0010.0310.
4
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.前瞻性评估抗凝和经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成。
Liver Int. 2012 Jul;32(6):919-27. doi: 10.1111/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.
5
Outcome of paediatric portopulmonary hypertension in the modern management era: A case report of 6 patients.儿科门脉肺高压的现代治疗结果:6 例病例报告。
J Hepatol. 2021 Mar;74(3):742-747. doi: 10.1016/j.jhep.2020.11.039. Epub 2020 Dec 1.
6
What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis.何种干预方案对肝硬化伴门静脉高压症患者脾切除术后预防门静脉系统血栓形成最有效?系统评价和网络荟萃分析。
Pharmacol Res. 2020 Jul;157:104825. doi: 10.1016/j.phrs.2020.104825. Epub 2020 Apr 21.
7
Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.经颈静脉肝内门体分流术后的肺动脉高压:对右心室功能的影响
Hepatology. 1996 May;23(5):982-7. doi: 10.1053/jhep.1996.v23.pm0008621179.
8
[Compartmentalized portal hypertension after spleno-renal shunt occlusion (author's transl)].脾肾分流闭塞后局限性门静脉高压症(作者译)
Sem Hop. 1981;57(25-28):1209-11.
9
[Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia].[脾髓样化生患者继发于肺动脉高压的呼吸困难]
Rev Med Interne. 2009 Sep;30(9):803-5. doi: 10.1016/j.revmed.2009.01.008. Epub 2009 Aug 11.
10
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.经颈静脉肝内门体分流术治疗肝硬化合并门静脉血栓形成并出现症状性门静脉高压。
J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.

引用本文的文献

1
Murine study of portal hypertension associated endothelin-1 hypo-response.门静脉高压相关内皮素-1低反应的小鼠研究
World J Gastroenterol. 2015 Apr 28;21(16):4817-28. doi: 10.3748/wjg.v21.i16.4817.

本文引用的文献

1
Clinical management of portopulmonary hypertension.门肺高压的临床管理
Hepatobiliary Pancreat Dis Int. 2007 Oct;6(5):464-9.
2
Portopulmonary hypertension.门肺高压
Clin Liver Dis. 2006 Aug;10(3):653-63, x. doi: 10.1016/j.cld.2006.08.023.
3
Clinical classification of pulmonary hypertension.肺动脉高压的临床分类
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):5S-12S. doi: 10.1016/j.jacc.2004.02.037.
4
Systemic and regional changes in plasma endothelin following transient increase in portal pressure.门静脉压力短暂升高后血浆内皮素的全身和局部变化。
Liver Transpl. 2003 Jan;9(1):32-9. doi: 10.1053/jlts.2003.50007.
5
Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations.原发性肺动脉高压与门脉高压之间的关联:对其病理生理学以及临床、实验室和血流动力学表现的分析。
J Am Coll Cardiol. 1991 Feb;17(2):492-8. doi: 10.1016/s0735-1097(10)80121-4.
6
Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics.门静脉高压合并肺动脉高压:患病率及其与内脏血流动力学的关系。
Gastroenterology. 1991 Feb;100(2):520-8. doi: 10.1016/0016-5085(91)90225-a.

一名患有门腔分流血栓形成的肝硬化患者出现失代偿性门脉肺动脉高压。

Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt.

作者信息

Giannarelli Chiara, De Giorgi Antonio, De Negri Ferdinando, Carmassi Franco

机构信息

Department of Internal Medicine, University of Pisa, via Roma 67, Pisa 56126, Italy.

出版信息

World J Gastroenterol. 2007 Dec 21;13(47):6439-40. doi: 10.3748/wjg.v13.i47.6439.

DOI:10.3748/wjg.v13.i47.6439
PMID:18081237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4205467/
Abstract

We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.

摘要

我们报告一例与肝内门腔分流血栓形成密切相关的失代偿性门脉肺动脉高压病例。一名患有Laennec肝硬化的女性因严重呼吸困难和水肿入院。她十年前接受了外科门腔静脉吻合术。影像学检查显示分流内大量血栓形成、门静脉高压、腹水、胸膜心包积液及右心腔扩大。心脏导管检查排除了冠状动脉和左心异常,诊断为毛细血管前性肺动脉高压。开始使用低分子量肝素进行抗血栓治疗。治疗还包括使用血管紧张素转换酶抑制剂、螺内酯、低盐饮食和乳果糖。患者出院,三个月后我们观察到水肿、腹水和胸膜心包积液消失,体重显著减轻,呼吸困难及肝功能检查改善。我们推测患者分流内血栓形成与临床失代偿之间可能存在联系。事实上,已经证明门体分流闭塞导致的门静脉压力升高会减少肾血浆流量并增加全身内皮素-1浓度。在我们的患者中,分流再通后水肿状态消失且呼吸困难改善,有力地支持了这一假说。